Companies
Oura
manufactures a ring-form wearable tracking physiological signal including cardiovascular and respiratory data through photoplethysmography (PPG), large enough to purchase a permanent San Francisco headquarters building and partner with a fertility-research clinic on physiological-signal studies.
- Country
- Finland
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | $2B projected for fiscal year 2026 (2026-09-30) | exitsandoutcomes.com |
| Headcount | 1,141 employees (2026-09-01) | ouraring.com |
| Production site | Sanmina provides manufacturing solutions (2015-08-27) | sanmina.com |
| Certification | MIC (Ministry of Internal Affairs and Communications) certification for Japan (2026-06-19) | support.ouraring.com |
| Regulatory approval | Oura ring is compatible with FDA-cleared Natural Cycles app (2022-08-02) | ouraring.com |
Independent sources: exitsandoutcomes.com · sanmina.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Sleep and circadian bioeconomy | diagnostics-medtech | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.